Weekly administration of dipeptidyl peptidase inhibitors

Details Weekly administration of dipeptidyl peptidase inhibitors Weekly administration of dipeptidyl peptidase inhibitors

A - Human Necessities

61

K

A61K 31/513 (2006.01) A61P 3/10 (2006.01) A61P 31/18 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2680006

Pharmaceutical compositions comprising 2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile and pharmaceutically acceptable salts thereof are provided as well as kits and articles of manufacture comprising the pharmaceutical compositions as well as methods of using the pharmaceutical compositions.

L'invention concerne des compositions pharmaceutiques comprenant 2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile et des sels pharmaceutiquement acceptables de celles-ci, ainsi que des kits et des articles manufacturés comprenant les compositions pharmaceutiques, et des procédés d'utilisation de ces compositions pharmaceutiques.

Affiliated with

Also associated with

Rating

Weekly administration of dipeptidyl peptidase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Weekly administration of dipeptidyl peptidase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Weekly administration of dipeptidyl peptidase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1766921